Rheumatoid arthritis

Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years

Kevin L Winthrop, Yoshiya Tanaka, Tsutomu Takeuchi, Alan Kivitz, Franziska Matzkies, Mark C Genovese, Deyuan Jiang, Kun Chen, Beatrix Bartok, Angelika Jahreis, Robin Besuyen, Gerd R Burmester, Jacques-Eric Gottenberg

10.1136/annrheumdis-2021-221051

November 5, 2021

Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database

Peter C Taylor, Tsutomu Takeuchi, Gerd R Burmester, Patrick Durez, Josef S Smolen, Walter Deberdt, Maher Issa, Jorge Ross Terres, Natalia Bello, Kevin L Winthrop

10.1136/annrheumdis-2021-221276

October 27, 2021

Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong

Xue Li, Xinning Tong, Winnie Wan Yin Yeung, Peng Kuan, Samson Hin Hei Yum, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Eric Yuk Fai Wan, Carlos King Ho Wong, Esther Wai Yin Chan, Chak Sing Lau, Ian Chi Kei Wong

10.1136/annrheumdis-2021-221571

October 22, 2021

Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy

Alejandro Ibáñez-Costa, Carlos Perez-Sanchez, Alejandra María Patiño-Trives, Maria Luque-Tevar, Pilar Font, Ivan Arias de la Rosa, Cristobal Roman-Rodriguez, Mª Carmen Abalos-Aguilera, Carmen Conde, Antonio Gonzalez, Sergio Pedraza-Arevalo, Mercedes del Rio-Moreno, Ricardo Blazquez-Encinas, Pedro Segui, Jerusalem Calvo, Rafaela Ortega Castro, Alejandro Escudero-Contreras, Nuria Barbarroja, Mª Angeles Aguirre, Justo P Castaño, Raul M Luque, Eduardo Collantes-Estevez, Chary Lopez-Pedrera

10.1136/annrheumdis-2021-220308

October 8, 2021

Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials

Kevin L Winthrop, Peter Nash, Kunihiro Yamaoka, Eduardo Mysler, Nasser Khan, Heidi S Camp, Yanna Song, Jessica L Suboticki, Jeffrey R Curtis

10.1136/annrheumdis-2021-220822

October 6, 2021

Baseline predictors of different types of treatment success in rheumatoid arthritis

Dafne Capelusnik, Daniel Aletaha

10.1136/annrheumdis-2021-220853

October 4, 2021

Loss of balance between protective and pro-inflammatory synovial tissue T-cell polyfunctionality predates clinical onset of rheumatoid arthritis

Achilleas Floudas, Nuno Neto, Carl Orr, Mary Canavan, Phil Gallagher, Conor Hurson, Michael G Monaghan, Sunil Nagpar, Ronan H Mullan, Douglas J Veale, Ursula Fearon

10.1136/annrheumdis-2021-220458

October 1, 2021

Joint inflammation tends to recur in the same joints during the rheumatoid arthritis disease course

Sascha L Heckert, Sytske Anne Bergstra, Xanthe M E Matthijssen, Yvonne P M Goekoop-Ruiterman, Faouzia Fodili, Saskia ten Wolde, Cornelia F Allaart, Tom W J Huizinga

10.1136/annrheumdis-2021-220882

August 30, 2021

Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment

Karen Holten, Nina Paulshus Sundlisater, Siri Lillegraven, Joseph Sexton, Lena Bugge Nordberg, Ellen Moholt, Hilde Berner Hammer, Till Uhlig, Tore K Kvien, Espen A Haavardsholm, Anna-Birgitte Aga

10.1136/annrheumdis-2021-220750

August 13, 2021

Trajectory clusters of radiographic progression in patients with rheumatoid arthritis: associations with clinical variables

Alexander Platzer, Farideh Alasti, Josef S Smolen, Daniel Aletaha, Helga Radner, Stephan Blüml

10.1136/annrheumdis-2021-220331

August 10, 2021